mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.8 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |